BiotechTube
Home/NorthStrive Biotherapeutics/Graydon Bensler, CFA
GB

Graydon Bensler, CFA

Chief Executive Officer & Chief Financial Officer

NorthStrive Biotherapeutics

Therapeutic Areas

ObesityMetabolic Disorders

NorthStrive Biotherapeutics Pipeline

DrugIndicationPhase
EL-22Preservation of lean muscle mass in patients on GLP-1 therapy for obesityPhase 1

Leadership Team at NorthStrive Biotherapeutics

BL
Braeden Lichti
Chairman
DM
Deniel Mero
Co-Founder
View full NorthStrive Biotherapeutics profile